ANDA 220768, held by Micro Labs. Fluvoxamine Maleate.
As of Nov 16, 2026, ANDA 220768 (Fluvoxamine Maleate), held by Micro Labs, was first approved by FDA on Jun 23, 2026, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 23, 2026 | Original application | Approved | None posted |
| Fluvoxamine Maleate100MG · capsule, extended release;oral | Fluvoxamine Maleate | Rx |
| Fluvoxamine Maleate150MG · capsule, extended release;oral | Fluvoxamine Maleate | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters